Selenium and Hashimoto's Thyroiditis: Why Brazil Nuts Aren't a Drug

Selenium supplementation modestly lowers thyroid peroxidase antibodies in Hashimoto's, but the clinical effect is smaller than supplement marketers claim, and Brazil nuts are an unreliable way to dose it. After eight randomized trials and three meta-analyses, the honest summary is this: selenium probably reduces TPO-Ab by 20–40 percent over six months. Whether that changes how you feel, how much levothyroxine you need, or whether you progress to overt hypothyroidism is far less clear.

The thyroid-selenium biology

The thyroid concentrates more selenium per gram than any other organ. Three selenoenzyme families matter for thyroid function: deiodinases (which convert T4 to T3), glutathione peroxidases, and thioredoxin reductases. The latter two scavenge the hydrogen peroxide generated during thyroid hormone synthesis. The mechanistic argument for supplementation is that low selenium status leaves the thyroid gland under more oxidative stress, which in turn drives autoantibody production and follicular damage.

This is biologically plausible, and selenium status varies dramatically by geography. People in central Europe, parts of China, and northern New Zealand tend to be selenium-deficient. Americans on a typical mixed diet usually are not.

What the trials show

The landmark trial was Gärtner et al. in 2002, which randomized 70 women with Hashimoto's to 200 µg sodium selenite or placebo for three months. TPO-Ab fell 36 percent in the selenium group versus 12 percent in placebo. Mazokopakis replicated the effect in 2007 with selenomethionine. A 2010 meta-analysis by Toulis pooled four trials and confirmed the antibody reduction. Wichman et al. published an updated 2016 systematic review identifying nine RCTs and concluding the evidence supported a TPO-Ab reduction but no clear benefit on TSH, free T4, or quality-of-life scores.

The CATALYST trial (2024, Denmark) is the largest selenium trial ever conducted in newly diagnosed Hashimoto's: 412 patients, 200 µg/day selenium-enriched yeast for 12 months. The primary outcome — change in thyroid hormone replacement need — was negative. TPO-Ab dropped, again, but disease progression markers did not differ from placebo. This is the trial supplement marketers don't cite.

Why Brazil nuts can't replace a measured dose

Brazil nuts are the most concentrated dietary source of selenium on Earth, but the content varies more than 100-fold depending on soil. A 2003 USDA analysis found nuts ranging from 8 µg to 1,917 µg per nut. A handful from one bag could deliver 50 µg; a handful from another could deliver more than 1,000 µg, which exceeds the tolerable upper intake (400 µg/day for adults). Selenium toxicity — selenosis — produces hair loss, brittle nails, garlic breath, and peripheral neuropathy. Cases have been reported from contaminated supplements delivering 200 times the labeled dose, but also from people eating a dozen Brazil nuts daily for chronic disease prevention.

Who is most likely to benefit

The trials that found the largest TPO-Ab reductions enrolled patients with baseline selenium below the population median or with antibody titers above 1,000 IU/mL. People with already-high serum selenium (above 130 µg/L) show no antibody response in subgroup analyses. Selenium status is rarely measured in primary care, but a serum or whole-blood selenium test is inexpensive and gives a meaningful answer.

Patients with Graves' ophthalmopathy are a separate population with stronger evidence: the EUGOGO randomized trial showed selenium 200 µg/day improved eye-related quality of life and slowed progression in mild orbitopathy.

Practical guidance

If your endocrinologist agrees a trial is reasonable, 200 µg/day of selenomethionine for six months is the dose the antibody studies used. Selenium-enriched yeast performs similarly. Re-test TPO-Ab at the end. If your level was already low or didn't move, there's no reason to continue. Selenium has a narrow therapeutic window — the U-shaped curve where deficiency and excess both raise mortality risk is well documented in NHANES data. Stay below the 400 µg/day tolerable upper limit, and don't combine a 200 µg supplement with a daily Brazil nut habit unless you've measured your status.

Selenium is not a substitute for levothyroxine when one is needed, and no trial has shown that selenium prevents progression from euthyroid Hashimoto's to overt hypothyroidism. The most defensible use case is a six-month, antibody-guided trial in a patient with low or unmeasured selenium status — not lifelong daily supplementation justified by a folk remedy.